Table 4.
Effect of 12-week synbiotic intervention on plasma antioxidant status in overweight and obese subjects.
| Parameters | Baseline | Week 6 | Week 12 |
|---|---|---|---|
| TEAC (µmol/L) | |||
| Placebo group | 1312.59 ± 155.59 Aa | 1303.81 ± 173.58 Aa | 1254.42 ± 195.54 Aa |
| Synbiotic group | 1265.07 ± 70.35 Aa | 1307.78 ± 170.22 Aa | 1340.34 ± 70.25 Bb |
| Thiol (mmol/L) | |||
| Placebo group | 38.78 ± 8.46 Aa | 38.47 ± 6.07 Aa | 42.12 ± 5.73 Ab |
| Synbiotic group | 39.93 ± 5.50 Aa | 39.69 ± 3.92 Aa | 42.52 ± 5.05 Ab |
| MDA (µmol/L) | |||
| Placebo group | 0.29 ± 0.31 Aa | 0.61 ± 0.47 Ab | 1.82 ± 0.94 Ab |
| Synbiotic group | 0.50 ± 0.44 Ba | 0.27 ± 0.49 Ba | 0.11 ± 0.11 Bb |
Values are represented as mean ± SD. Means in the same column with a different uppercase superscript (A, B: treatment effects) indicate a significant difference (p < 0.05) between groups. Means in the same row with a different lowercase superscript (a, b: time effect) indicate a significant difference (p < 0.05) when compared to baseline. TEAC; Trolox equivalent antioxidant capacity, MDA; malonaldehyde.